|
BIRC2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.340900E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.172380E-02 |
| Normal-vs-Stage2 |
5.185600E-01 |
| Normal-vs-Stage3 |
4.101800E-02 |
| Normal-vs-Stage4 |
1.383520E-03 |
| Stage1-vs-Stage2 |
4.038000E-01 |
| Stage1-vs-Stage3 |
5.739800E-01 |
| Stage1-vs-Stage4 |
1.951020E-01 |
| Stage2-vs-Stage3 |
3.123800E-01 |
| Stage2-vs-Stage4 |
1.015190E-01 |
| Stage3-vs-Stage4 |
4.198800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.956600E-03 |
| Normal-vs-AfricanAmerican |
1.106380E-01 |
| Normal-vs-Asian |
6.038200E-01 |
| Caucasian-vs-AfricanAmerican |
4.860000E-01 |
| Caucasian-vs-Asian |
8.671600E-01 |
| AfricanAmerican-vs-Asian |
9.416000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.598600E-03 |
| Normal-vs-Female |
3.737200E-01 |
| Male-vs-Female |
5.001600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.872300E-02 |
| Normal-vs-Extreme_Weight |
2.061800E-03 |
| Normal-vs-Obese |
1.047640E-01 |
| Normal-vs-Extreme_Obese |
1.188380E-02 |
| Normal_Weight-vs-Extreme_Weight |
8.732000E-01 |
| Normal_Weight-vs-Obese |
3.321200E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.951200E-01 |
| Extreme_Weight-vs-Obese |
1.733200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.167600E-01 |
| Obese-vs-Extreme_Obese |
2.397400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.030400E-01 |
| Normal-vs-Age(41-60Yrs) |
2.649600E-01 |
| Normal-vs-Age(61-80Yrs) |
4.370700E-04 |
| Normal-vs-Age(81-100Yrs) |
1.018180E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.677200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.116400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.439700E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.683800E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.256420E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.049600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.472000E-02 |
| Normal-VS-Type2 PRCC |
3.381600E-04 |
| Normal-VS-KIRP CIMP |
5.745600E-02 |
| Normal-VS-Unclassified PRCC |
7.494600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.366180E-02 |
| Type1 PRCC-VS-KIRP CIMP |
5.143200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.321400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.591800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.267700E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
3.734600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.053720E-02 |
| Normal-vs-N1 |
2.406400E-02 |
| Normal-vs-N2 |
6.542400E-03 |
| N0-vs-N1 |
9.896400E-01 |
| N0-vs-N2 |
3.524600E-01 |
| N1-vs-N2 |
3.158800E-01 |
|
|
